Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,102 | 0,108 | 25.06. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
29.04. | Presentation at CFA Congress of Positive Results Obtained for SpineGuard's New Ultrasound Technology | 320 | Business Wire | Feasibility of entry point and trajectory determination in vertebral drilling
Ideal complement of DSG real-time X Ray-free guidance technology
Collaboration with the LIB and ISIR... ► Artikel lesen | |
15.04. | SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales | 304 | Business Wire | Significant reduction in losses of €1.1 million, with consolidated net income improving by 26% in 2024
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen | |
09.04. | SpineGuard and Omnia Medical Announce the Signature of a Binding Term Sheet for the Transfer of SpineGuard Inc. | 270 | Business Wire | Taking a new strategic step forward in the implementation of the common roadmap established by the two companies announced on January 6, 2025 Integration of PediGuard systems into Omnia... ► Artikel lesen | |
14.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | 1.192 | Xetra Newsboard | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
SPINEGUARD Aktie jetzt für 0€ handeln | |||||
10.02. | SpineGuard Announces the Commercial Launch of its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 345 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Omnia launched PsiFGuard at the NANS convention in Orlando, from Jan. 30th to Feb. 1st, 2025
Regulatory News:
SpineGuard... ► Artikel lesen | |
10.01. | SpineGuard Reports Its Full-Year 2024 Revenue | 608 | Business Wire | +8% growth globally, +20% in the US
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology... ► Artikel lesen | |
07.01. | SpineGuard Completes a Bond Financing to Support the Deployment of Its New Products | 961 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
06.01. | SpineGuard and Omnia Medical Announce the Extension of Their Strategic Partnership | 479 | Business Wire | Scope of initial agreement extended to other products and countries Reallocation of personnel and resources to bolster the launch of Omnia products in the United States including PsiFGuard
Regulatory... ► Artikel lesen | |
03.01. | SpineGuard announces its 2025 financial calendar | 474 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
09.10.24 | SpineGuard Announces Its Q3 2024 Revenue | 511 | Business Wire | Growth acceleration to continue in Q3 2024: +20% globally and +30% in the US Revenue up +13% over the first 9 months, to €3.6 million
Regulatory News:
SpineGuard (FR0011464452 ALSGD)... ► Artikel lesen | |
30.09.24 | SpineGuard Obtains FDA Clearance for Commercial Release of Its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 487 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Key milestone for the deployment of the DSG technology in the United States
Regulatory News:
SpineGuard (FR0011464452... ► Artikel lesen | |
11.09.24 | SpineGuard Reports its H1 2024 Financial Results | 418 | Business Wire | Revenue growth by 10% at constant exchange rate Net loss reduced by 20% and EBITDA improved by 30%
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen | |
03.09.24 | SpineGuard obtains EC-MDR certification and launches its Threaded PediGuard for anterior spine surgery in Europe | 541 | Business Wire | Regulatory News:
SpineGuard (Paris:ALSGD)(FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline... ► Artikel lesen | |
17.07.24 | SpineGuard Files Its "510K" Dossier in the US for the Clearance of Its New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 668 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Acceleration of commercial deployment of SpineGuard in the United States
Regulatory News:
SpineGuard (FR0011464452... ► Artikel lesen | |
15.07.24 | SpineGuard Announces its H1 2024 Revenue | 339 | Business Wire | Growth acceleration in Q2, +14% globally (+26% in the US) 10% growth at constant exchange rate in the first half
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company... ► Artikel lesen | |
26.06.24 | SpineGuard Reports on Its Annual Shareholders' Meeting of June 26, 2024 | 405 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 41,950 | -0,73 % | Aktienmarkt: Fresenius SE & Co. KGaA-Aktie kann sich nicht behaupten (42,16 €) | Der Anteilsschein von Fresenius SE & Co. KGaA notiert am Mittwoch leichter. Die Aktie kostete zuletzt 42,16 Euro. Für Inhaber von Fresenius+Co KgaA ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,970 | +0,15 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
TELADOC HEALTH | 6,493 | -0,08 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace) | ||
THERMO FISHER | 353,40 | +0,31 % | Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply | Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration... ► Artikel lesen | |
EUROFINS SCIENTIFIC | 60,10 | +0,03 % | Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
SYNLAB | 12,790 | +0,08 % | Synlab Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
DAVITA | 120,85 | +0,33 % | 3 Takeaways From DaVita CEO Javier Rodriguez on the Future of Health Technology | NORTHAMPTON, MA / ACCESS Newswire / June 20, 2025 / Health care conversations have outgrown the concept of transformation; what we need now is a revolution, driven by the capabilities of cutting-edge... ► Artikel lesen | |
SPINEWAY | 0,118 | 0,00 % | Spineway: Minutes of the General Meeting of June 4, 2025 | Press release Ecully, June 6, 2025 - 6.00 p.m. SPINEWAY Minutes of the General Meeting of June 4, 2025 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders... ► Artikel lesen | |
DENTSPLY SIRONA | 13,345 | -2,77 % | DENTSPLY SIRONA Inc.: Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer | CHARLOTTE, N.C., May 29, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced that Matthew E. Garth has been appointed Executive Vice President... ► Artikel lesen | |
SMITH & NEPHEW | 13,030 | +0,73 % | Smith & Nephew UK Ltd: Smith+Nephew's new TRIGEN MAX Tibia Nailing System brings 'next-level nailing' to trauma surgeons repairing tibial fractures | The future of fracture fixation with novel side-specific nails featuring variable angle locking technology
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces... ► Artikel lesen | |
SONIC HEALTHCARE | 14,402 | -0,01 % | SONIC HEALTHCARE LIMITED: Change in substantial holding | ||
EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
ONTRAK | 0,970 | -7,62 % | Ontrak, Inc. - S-1/A, General form for registration of securities | ||
DIASORIN | 94,90 | +1,26 % | Dividendenbekanntmachungen (21.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AFLAC INC US0010551028 0,58 USD 0,5141 EUR ARCHER DANIELS MIDLAND COMPANY US0394831020 0,51 USD 0,452 EUR ASSECO BUSINESS SOLUTIONS... ► Artikel lesen | |
PATTERSON COMPANIES | 27,400 | 0,00 % | Patterson Companies Completes Acquisition by Patient Square Capital | Robert Rajalingam Appointed Chief Executive Officer and to Board of Directors
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies ("Patterson" or the "Company"), a leading supplier of products... ► Artikel lesen |